This article has multiple issues. Please help  improve it  or discuss these issues on the  talk page . (Learn how and when to remove these messages) 
 
  | 
    | |
| Company type | Private | 
|---|---|
| Industry | Health care | 
| Founded | 2005 | 
| Founder | Christophe Llorens (CEO) | 
| Headquarters |  Geneva (GE), Switzerland  | 
Area served  | Worldwide | 
Key people  | Raphael Llorens | 
| Website |  zsimplants | 
Zephyr Surgical Implants (ZSI) is a Swiss-based medical device manufacturer that produces and distributes artificial urinary sphincters and penile implants worldwide. ZSI products are used in the management of moderate-to-severe urinary incontinence in men, erectile dysfunction, Peyronie's disease, penis enlargement, and female-to-male gender reassignment surgery.
The company was founded by Dr. Christophe Llorens and Raphael Llorens in 2005. [1] The first product – ZSI 375 artificial urinary sphincter, was introduced in 2009. [2] [3] As of 2019, more than 4500 ZSI 375 artificial urinary sphincters were implanted worldwide. [2] The inflatable penile implant designed for female-to-male gender reassignment surgeries became available in the European market in March 2016, and the first phalloplasty procedures using ZSI 475 FtM implants were performed in June 2016. [4]
Many clinical studies have been performed with the artificial urinary sphincter ZSI 375 in the treatment of moderate and severe stress incontinence, most of them are retrospective and non-randomized tests. Success rates in total or social continence vary, in a period of 6 to 24 months, between 68 and 89%. [5] [6]